Table 2: Major adverse cardiac and cerebrovascular events (MACCE) and other events after SFA CTO revascularization stratified by DM presence.

All patients ()DM ()Non-DM () value

TVR (n, %)18 (20.9)9 (18)9 (25)0.4
Non-TVR (n, %)23 (26.7)13 (26)10 (27.8)0.8
Amputation (n, %)4 (4.6)3 (6)1 (2.8)0.8
Stroke (n, %)000‚ÄČ
ACS (n, %)3 (3.5)2 (4)1 (2.8)0.8
All-cause mortality (n, %)6 (6.9)6 (12)00.038
Unsuccessful revascularization (n, %)5 (5.8)2 (4)3 (8.3)0.6

ACS: acute coronary syndrome; CTO: chronic total occlusion; SFA: superficial femoral artery; non-TVR: nontarget vessel revascularization; TVR: target vessel revascularization.